Patients with early Parkinson disease who received lixisenatide had a decrease in motor disability progression, but they also experienced gastrointestinal side effects. Lixisenatide vs placebo is ...

A recent study published in the New England Journal of Medicine conducted a trial of lixisenatide to assess its effects in early Parkinson’s disease. Study: Trial of Lixisenatide in Early Parkinson’s ...

An older diabetes treatment called lixisenatide resulted in less progression of motor disability after 12 months in patients in an early stage of the disease Erin Clack is a Staff Editor for PEOPLE.

FOR THOSE WITH NEUROLOGICAL AND MOTOR DISABILITIES. IT BEGAN MORE THAN 20 YEARS AGO BY A LOCAL COUPLE LOOKING FOR A WAY TO HELP THEIR SON AFTER HE WAS DIAGNOSED WITH CEREBRAL PALSY. MEET VICKI AND JOE ...

A recent study published in The New England Journal of Medicine has demonstrated that lixisenatide, a glucagon-like peptide-1 (GLP-1) receptor agonist, may slow the progression of motor disability in ...

Please provide your email address to receive an email when new articles are posted on . Students with a chronic illness, sensory or motor disability or multiple disabilities often experience ...

FARGO — North Dakota State University students are making the holidays a lot easier for children of all abilities. Playing with toys isn't possible at times for children with physical and motor ...

DUARTE, Calif., Aug. 20, 2025 /PRNewswire/ -- A groundbreaking study has revealed something remarkable about premature babies fed Prolacta Bioscience's Exclusive Human Milk Diet (EHMD): Despite being ...

Changes in motor units closely reflect disease severity in people with spinal muscular atrophy (SMA), suggesting potential new biomarkers.